Recent studies addressed the question of the impact of tumor infiltration by B cells and presence of TLS on patient survival and response to PD-1 blockade in soft-tissue sarcoma (50) and to PD-1 and CTLA-4 blockade in melanoma (51, 52). This evidence concerns the gene CTLA4 and neoplasm.